|
|
Recent Articles
-
Tyson’s Pricing Strength Enables Margin Expansion During Turbulent Time
Nov 22, 2021
-
Image Shown: Tyson Foods Inc put up stellar results for fiscal 2021. Image Source: Tyson Foods Inc – Fourth Quarter of Fiscal 2021 IR Earnings Presentation.
On November 15, Tyson Foods reported fourth quarter earnings for fiscal 2021 (period ended October 2, 2021) that beat both consensus top- and bottom-line estimates largely due to the firm’s impressive pricing strength, the focus of this article. The company is facing major headwinds from the coronavirus (‘COVID-19’) pandemic, from labor shortages to supply chain bottlenecks to rising input costs, though Tyson has adeptly navigated this turbulence while bolstering both its revenues and its margins.
-
ICYMI: The PayPal Wave Recedes, We Still Like Shares
Nov 22, 2021
-
Image Source: PayPal.
We knew something wasn’t quite lining up at digital-payments provider PayPal when the rumor mill started to turn with reports it was interested in scooping up Pinterest for a pretty penny. PayPal has since put to rest rumors about buying Pinterest, but it left investors with a sour outlook when it issued third-quarter results November 8. Though the market wasn’t happy with the forecast for the fourth quarter of 2021 and into 2022, the company continues to grow revenue at a robust pace, and we expect several key initiatives to drive sustainable top-line expansion for many years to come. Our fair value estimate stands north of $270 per share.
-
Shares of Dividend Growth Idea Qualcomm Surge Higher
Nov 19, 2021
-
Image Shown: Shares of dividend growth idea Qualcomm Inc have skyrocketed since the start of November in the wake of its latest earnings update and favorable guidance put out during a recent investor day event.
Over the next decade, dividend growth idea Qualcomm expects its addressable market opportunity will grow by $100 billion, reaching $700 billion, according to guidance put out during a big Investor Day event held on November 16. We appreciate Qualcomm’s ever-expanding growth runway and include shares of QCOM as an idea in the Dividend Growth Newsletter portfolio. On November 3, Qualcomm reported fourth-quarter fiscal 2021 earnings (period ended September 26, 2021) that beat both consensus top- and bottom-line estimates. Additionally, Qualcomm provided strong guidance for its first-quarter fiscal 2022 in conjunction with that report. Shares of Qualcomm have been off to the races since then, and as of this writing, shares of QCOM yield ~1.5%.
-
Cisco Systems Posts Solid Earnings Update; Supply Chain Hurdles Impacting Near Term Outlook
Nov 19, 2021
-
Image Source: Cisco Systems Inc – First Quarter of Fiscal 2022 IR Earnings Presentation.
On November 17, Cisco Systems reported first quarter earnings for fiscal 2022 (period ended October 30, 2021) that missed consensus top-line estimates but beat consensus bottom-line estimates. Shares of CSCO fell initially after its latest earnings update was published due to its near-term guidance coming in a tad softer than expected, though we caution that this is primarily due to supply chain headwinds negatively impacting Cisco Systems and the networking hardware industry more broadly. As global health authorities work towards bringing the coronavirus (‘COVID-19’) pandemic to an end worldwide, the supply chain situation should improve going forward. We include Cisco Systems as an idea in both the Best Ideas Newsletter and Dividend Growth Newsletter portfolios. As of this writing, shares of CSCO yield ~2.6%.
-
Update: Johnson & Johnson Is A Stellar Company With Ample Upside
Nov 19, 2021
-
Image Source: Johnson & Johnson – Third Quarter of Fiscal 2021 IR Earnings Presentation.
We view Johnson & Johnson's capital appreciation and dividend growth upside potential quite favorably. The top end of our fair value estimate range sits at $206 per share of JNJ. In this article, we cover Johnson & Johnson's stellar financial performance, recent guidance boosts, and some of its legal hurdles. Johnson & Johnson announced on November 12 that it would spinoff its consumer-facing operations while retaining its medical devices and pharmaceutical operations.
|
